Migraine, Mental Health, and Marginalization: A Study of Psychiatric Comorbidities in a Multiethnic Cohort from Quetta, Pakistan
Abstract
Background: Migraine is the most common cause of disability in the world, and it often happens along with psychiatric disorders. This study aimed to examine the correlation between migraine and psychiatric comorbidities in Balochistan. Methods: A cross-sectional study involving 349 migraine patients (70.8% female; mean age 38.2 ± 12.5 years) was undertaken from January 2023 to December 2024. Validated instruments (PHQ-9, GAD-7, MIDAS, SF-36) and structured interviews evaluated psychiatric comorbidities, migraine features, disability, and quality of life. Descriptive statistics, bivariate analysis, and logistic regression models determined the predictors of depression and anxiety. Results: Psychiatric comorbidities were frequent, with 44.7% (n = 156) screening positive for depression (PHQ-9 ≥10) and 38.1% (n = 133) for anxiety (GAD-7 ≥10). Patients with chronic migraines demonstrated elevated rates of depression (67.8% vs. 40.0%) and anxiety (61.0% vs. 33.4%) in comparison to those with episodic migraines. Sociodemographic factors, such as illiteracy (51.9%). Logistic model indicated chronic migraine (aOR = 2.8, 95% CI: 1.9–4.0), female gender (aOR = 2.1, 95% CI: 1.4–3.2), illiteracy (aOR = 1.7, 95% CI: 1.1–2.6), and elevated stress (aOR = 3.5, 95% CI: 2.3–5.4) as independent predictors of depression. Patients with comorbidities had 50% reduced SF-36 scores and twice the number of disability days (MIDAS: 12.0 vs. 6.0 days/month). Conclusion: Migraine and psychiatric…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 349 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.